Nonsteroidal anti-inflammatory drug-induced hepatoxicity

Alberto Unzueta, Hugo E. Vargas

Research output: Contribution to journalReview article

33 Scopus citations


Nonsteroidal anti-inflammatory drugs are among the most prescribed medications worldwide. After antibiotics and anticonvulsants they are considered the most common medications associated with drug-induced liver injury mainly through an idiosyncratic form of hepatotoxicity. In rare cases severe hepatotoxicity has been described with significant morbidity and mortality. Genetic risk factors have been reported with diclofenac and lumiracoxib. Postmarketing surveillance and monitoring is crucial to identify severe cases of hepatotoxicity.

Original languageEnglish (US)
Pages (from-to)643-656
Number of pages14
JournalClinics in liver disease
Issue number4
StatePublished - Nov 1 2013


  • Acute liver injury
  • Drug safety
  • Drug surveillance
  • Drug-induced liver injury
  • Hy's law
  • Idiosyncratic hepatotoxicity
  • Liver transplantation
  • Nonsteroidal anti-inflammatory drugs

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Nonsteroidal anti-inflammatory drug-induced hepatoxicity'. Together they form a unique fingerprint.

  • Cite this